273 related articles for article (PubMed ID: 29203479)
1. Host-Pathogen-Treatment Triad: Host Factors Matter Most in Methicillin-Resistant Staphylococcus aureus Bacteremia Outcomes.
Guillamet MCV; Vazquez R; Deaton B; Shroba J; Vazquez L; Mercier RC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203479
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
Kızılarslanoğlu MC; Sancak B; Yağcı S; Hasçelik G; Unal S
Mikrobiyol Bul; 2013 Apr; 47(2):199-210. PubMed ID: 23621720
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
4. Long-term methicillin-resistant Staphylococcus aureus bacteremia persisting for more than 2 weeks: risk factors and outcomes.
Lee YM; Chong YP; Kim M; Eom Y; Kim ES; Kim M; Park KH; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS
Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):773-781. PubMed ID: 31873861
[TBL] [Abstract][Full Text] [Related]
5. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study.
Ho KM; Robinson JO
Anaesth Intensive Care; 2009 May; 37(3):457-63. PubMed ID: 19499868
[TBL] [Abstract][Full Text] [Related]
7. Using MRSA Screening Tests To Predict Methicillin Resistance in Staphylococcus aureus Bacteremia.
Butler-Laporte G; Cheng MP; Cheng AP; McDonald EG; Lee TC
Antimicrob Agents Chemother; 2016 Dec; 60(12):7444-7448. PubMed ID: 27736763
[TBL] [Abstract][Full Text] [Related]
8. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
[TBL] [Abstract][Full Text] [Related]
9. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
[TBL] [Abstract][Full Text] [Related]
10. Influence of antimicrobial regimen on decreased in-hospital mortality of patients with MRSA bacteremia.
Kaku N; Yanagihara K; Morinaga Y; Yamada K; Harada Y; Migiyama Y; Nagaoka K; Matsuda J; Uno N; Hasegawa H; Miyazaki T; Izumikawa K; Kakeya H; Yamamoto Y; Kohno S
J Infect Chemother; 2014 Jun; 20(6):350-5. PubMed ID: 24731430
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
[TBL] [Abstract][Full Text] [Related]
12. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH
Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132
[TBL] [Abstract][Full Text] [Related]
13. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
[TBL] [Abstract][Full Text] [Related]
14. Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants.
Shane AL; Hansen NI; Stoll BJ; Bell EF; Sánchez PJ; Shankaran S; Laptook AR; Das A; Walsh MC; Hale EC; Newman NS; Schrag SJ; Higgins RD;
Pediatrics; 2012 Apr; 129(4):e914-22. PubMed ID: 22412036
[TBL] [Abstract][Full Text] [Related]
15. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
Yaw LK; Robinson JO; Ho KM
Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and costs associated with a history of vancomycin exposure in patients with MRSA-related complicated bacteremia and infective endocarditis.
Brown J; Brown KA; Forrest A
Clin Ther; 2011 Oct; 33(10):1475-82. PubMed ID: 21925733
[TBL] [Abstract][Full Text] [Related]
17. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.
Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H
Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021
[TBL] [Abstract][Full Text] [Related]
18. Toxic Shock Syndrome Toxin 1-Producing Methicillin-Resistant Staphylococcus aureus of Clonal Complex 5, the New York/Japan Epidemic Clone, Causing a High Early-Mortality Rate in Patients with Bloodstream Infections.
Kim D; Hong JS; Yoon EJ; Lee H; Kim YA; Shin KS; Shin JH; Uh Y; Shin JH; Park YS; Jeong SH
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501145
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study.
Wang JT; Hsu LY; Lauderdale TL; Fan WC; Wang FD
PLoS One; 2015; 10(12):e0144710. PubMed ID: 26690351
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality.
Bassetti M; Peghin M; Trecarichi EM; Carnelutti A; Righi E; Del Giacomo P; Ansaldi F; Trucchi C; Alicino C; Cauda R; Sartor A; Spanu T; Scarparo C; Tumbarello M
PLoS One; 2017; 12(2):e0170236. PubMed ID: 28152067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]